4//SEC Filing
Lowdell Mark William 4
Accession 0001213900-24-106916
CIK 0001711754other
Filed
Dec 8, 7:00 PM ET
Accepted
Dec 9, 4:00 PM ET
Size
5.4 KB
Accession
0001213900-24-106916
Insider Transaction Report
Form 4
Inmune Bio, Inc.INMB
Lowdell Mark William
Chief Scientific Officer
Transactions
- Award
Option (right to buy)
2024-12-05+140,000→ 140,000 totalExercise: $5.05Exp: 2034-12-04→ Common Stock (140,000 underlying)
Footnotes (1)
- [F1]Granted pursuant to the 2021 Stock Incentive Plan. The option will become 100% vested and exercisable on December 5, 2026, the two-year anniversary of the grant date.
Documents
Issuer
Inmune Bio, Inc.
CIK 0001711754
Entity typeother
Related Parties
1- filerCIK 0001767037
Filing Metadata
- Form type
- 4
- Filed
- Dec 8, 7:00 PM ET
- Accepted
- Dec 9, 4:00 PM ET
- Size
- 5.4 KB